GTF2H1 rs4596 variant G, which is associated with a decreased risk of CRC, was predicted to reduce binding of miR-518a-5p and miR-527, leading to elevated GTF2H1 expression and NER pathway activity. The gene discussed is GTF2H1; the disease is colorectal carcinoma.